National Health Service Trials AI Software to Diagnose Breast Cancer

Several European companies have trained artificial intelligence to detect signs of breast cancer in scans. Several European companies have trained artificial intelligence (AI) to detect signs of breast cancer, in an effort to help hospitals contend with a shortage of radiologists. The U.K.'s Kheiron Medical, the latest company to announce it will use AI algorithms to try to diagnose breast cancer, launched a trial on historic scans at a National Health Service trust in Leeds. Kheiron's algorithms were trained on 500,000 scans from hospitals in Hungary. The company submitted its findings for peer review after concluding its technology beat the average performance of a human radiologist when tested against 3,500 scans.